Consistent with FDA labeling, GLP-1 RAs amplify hypoglycemia risk when combined with insulin or sulfonylureas 42 , a complication linked to seizures, syncope, and tremors 43
Inconsistent use of some GLP-1 weight-loss medications, like Ozempic and Wegovy, may significantly lessen their effectiveness, according to a new preclinical study from researchers at the Perelman School of Medicine at the University of Pennsylvania
These compounds have been associated with protection against insulin resistance, high cholesterol and neurodegenerative diseases
Also, observe your skins reaction and adjust the dosage accordingly
This protective effect has been substantiated through subgroup analyses stratified by histological type, race, gender, and smoking status [19]